Revolutionary Meniscus Repair Procedure by Crystal Clinic Sets New Standard in Orthopaedic Care

In a landmark achievement for orthopaedic medicine, Dr. Paul Fleissner, a board-certified orthopaedic and pediatric surgeon at the renowned Crystal Clinic Orthopaedic Center in Fairlawn, Ohio, has successfully executed the world's first-ever meniscus repair using an innovative regenerative implant known as RejuvaKnee™. This advanced surgical technique aims to redefine traditional treatment options for patients suffering from meniscal injuries, particularly for those who have previously endured meniscectomy procedures and continue to experience chronic pain. The new collagen-based implant, developed by Regenity Biosciences, recently received FDA approval, marking a significant milestone in medical technology. Pre-clinical studies have demonstrated its efficacy in promoting the regeneration of native meniscal tissue, offering hope for more complete recoveries in athletes and active individuals. As described by Dr. Fleissner, "This method is a true game-changer that can alter the way we approach meniscal restoration." The RejuvaKnee™ implant caters specifically to patients with irreparable meniscus tears, providing a more durable and effective solution compared to existing treatment modalities. An essential attribute of the RejuvaKnee™ is its availability, which minimizes wait times for surgery— a common concern in orthopaedic care that impacts patients' quality of life. Prolonged pain and restricted activity often accompany extended waits for surgical intervention. As Dr. Fleissner emphasizes, "Healthier outcomes should not be delayed simply due to a waiting list. This implant will alleviate that issue, allowing patients to receive timely treatment and return to their regular activities with confidence." Following this groundbreaking procedure, Dr. Fleissner plans to conduct additional surgeries using the RejuvaKnee™ in the coming weeks. He expresses optimism that this treatment can significantly enhance his patients' overall well-being and functionality. Crystal Clinic Orthopaedic Center stands out in the U.S. healthcare landscape, consistently earning accolades such as being named a Top 100 hospital nationally. With a commitment to excellence, this facility offers advanced treatments that reflect the latest developments in the field. As Dr. Fleissner advocates, providing cutting-edge healthcare resources to patients across the nation is a priority. For individuals looking for more information about these innovative procedures or seeking to schedule an appointment, Crystal Clinic is easily accessible at their website, CrystalClinic.com. About Crystal Clinic Orthopaedic Center: Crystal Clinic is a physician-owned orthopaedic hospital system, esteemed nationally for its specialized care. The expertise of its board-certified surgeons, many holding advanced fellowship qualifications, culminates in thousands of successful surgeries conducted annually. In addition to its top-tier orthopaedic services, the clinic offers a full spectrum of plastic and reconstructive care. Recognized as a leader in orthopaedic treatment, the hospital system currently operates 17 locations throughout Northeast Ohio, providing patient-centered care and immediate access to specialist services. About Regenity Biosciences: Operating within the Linden Capital Partners portfolio, Regenity Biosciences specializes in developing bioresorbable technologies tailored to repair and regenerate tissues across several medical markets, including orthopaedics. Based in Paramus, New Jersey, with additional manufacturing capabilities, the company has steadily established its presence since its inception in 1997. Through innovative collagen-based products and strategic partnerships, Regenity aims to advance patient care by enhancing recovery outcomes across various medical specialties.